Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management Purchases 108,000 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management grew its position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 117.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 200,000 shares of the company’s stock after buying an additional 108,000 shares during the period. VanEck Pharmaceutical ETF makes up 2.8% of Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management’s holdings, making the stock its 12th biggest position. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management owned 3.18% of VanEck Pharmaceutical ETF worth $17,256,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. FMR LLC raised its stake in VanEck Pharmaceutical ETF by 12.5% in the third quarter. FMR LLC now owns 1,905 shares of the company’s stock valued at $181,000 after purchasing an additional 212 shares in the last quarter. Edge Financial Advisors LLC acquired a new position in shares of VanEck Pharmaceutical ETF in the 3rd quarter valued at approximately $263,000. Harbour Investments Inc. lifted its holdings in shares of VanEck Pharmaceutical ETF by 16.6% during the 3rd quarter. Harbour Investments Inc. now owns 3,425 shares of the company’s stock worth $325,000 after acquiring an additional 488 shares during the period. Townsquare Capital LLC lifted its holdings in shares of VanEck Pharmaceutical ETF by 3.8% during the 3rd quarter. Townsquare Capital LLC now owns 3,519 shares of the company’s stock worth $334,000 after acquiring an additional 130 shares during the period. Finally, Assetmark Inc. boosted its position in shares of VanEck Pharmaceutical ETF by 5.8% during the 3rd quarter. Assetmark Inc. now owns 6,491 shares of the company’s stock worth $617,000 after acquiring an additional 354 shares in the last quarter.

VanEck Pharmaceutical ETF Price Performance

NASDAQ PPH opened at $86.86 on Friday. The business has a fifty day moving average price of $87.62 and a two-hundred day moving average price of $91.99. The stock has a market capitalization of $585.44 million, a PE ratio of 21.04 and a beta of 0.72. VanEck Pharmaceutical ETF has a fifty-two week low of $83.74 and a fifty-two week high of $99.51.

VanEck Pharmaceutical ETF Increases Dividend

The firm also recently disclosed a dividend, which was paid on Monday, December 30th. Investors of record on Friday, December 27th were paid a $0.411 dividend. The ex-dividend date of this dividend was Friday, December 27th. This is a positive change from VanEck Pharmaceutical ETF’s previous dividend of $0.36.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.